| 25/06/21 | NattoPharma ASA : - Delisting | AQ |
| 15/06/21 | NattoPharma : Received application for delisting | AQ |
| 14/06/21 | NattoPharma : Annual General Meeting in NattoPharma ASA | AQ |
| 10/06/21 | NattoPharma : OSLO BØRS - SUSPENDED | AQ |
| 09/06/21 | NattoPharma ASA: Compagnie des Levures Lesaffre announces compulsory acquisition | AQ |
| 1 day | +2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Kjetil Ramsøy
CEO | Chief Executive Officer | 54 | 08/02/2018 |
Robert Schrama
DFI | Director of Finance/CFO | - | 09/03/2020 |
Gunilla Traberg
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Frode Marc Bohan
CHM | Chairman | 58 | 04/11/2004 |
| Director/Board Member | 52 | 01/02/2011 | |
Kjetil Ramsøy
BRD | Director/Board Member | 54 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +1.46% | - | - | 86.2M | |
| -0.46% | -2.48% | +48.21% | +88.20% | 1,001B | |
| -0.31% | -3.41% | +48.94% | +63.44% | 642B | |
| +0.86% | +0.57% | +17.12% | +73.05% | 451B | |
| -0.38% | -3.59% | +28.24% | +35.57% | 340B | |
| -0.09% | -13.54% | +10.08% | +26.87% | 263B | |
| -0.43% | -2.48% | -2.07% | +11.48% | 247B | |
| -0.96% | -13.36% | +33.99% | +44.75% | 207B | |
| -3.44% | -7.51% | -20.08% | -59.58% | 197B | |
| -0.71% | -4.73% | +22.05% | +86.72% | 180B | |
| Average | -0.33% | -5.53% | +20.72% | +41.17% | 391.82B | |
| Weighted average by Cap. | -0.43% | -4.65% | +30.10% | +55.87% |
Employees
18
Sector
Pharmaceuticals
